News from Adaptive Biotechnologies Corporation A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

17 Mar, 2015, 08:00 ET Adaptive Biotechnologies Invited to Present at Upcoming Conferences

 Adaptive Biotechnologies Corporation, the pioneer in leveraging next generation sequencing to profile T-cell and B-cell receptors, today...


29 Sep, 2014, 11:41 ET Adaptive Biotechnologies Announces the Formation of a Hematologic Malignancies Scientific Advisory Board

Adaptive Biotechnologies, a clinical stage diagnostics company that leverages Next Generation Sequencing to profile the adaptive immune system,...


08 Jul, 2014, 11:08 ET Veteran Microsoft Executive and Distinguished Engineer, Sean Nolan, joins Adaptive Biotechnologies as Chief Technology Officer

Adaptive Biotechnologies, a clinical stage diagnostics company that leverages Next Generation Sequencing (NGS) to profile the adaptive immune...


27 May, 2014, 11:08 ET Adaptive Biotechnologies and Collaborators to Present Data Advancing the Clinical Utility of Immunosequencing at the 50th Annual Meeting of the American Society of Clinical Oncology

Adaptive Biotechnologies, the pioneer of Next Generation Sequencing of the adaptive immune system, and its collaborators will present data...


13 Jan, 2014, 11:08 ET Adaptive Announces a Biomarker Discovery Agreement with Johnson & Johnson Innovation

Adaptive Biotechnologies announced today a biomarker discovery agreement facilitated by the Johnson & Johnson Innovation Center in...


08 Jan, 2014, 11:08 ET Adaptive Biotechnologies CEO Selected To Present At 32nd Annual J.P. Morgan Healthcare Conference

Adaptive Biotechnologies (www.adaptivebiotech.com) announced today that Chad Robins, Founder and Chief Executive Officer, is scheduled to present a...


03 Dec, 2013, 13:08 ET Adaptive Biotechnologies and Collaborators Present 16 Studies Demonstrating Clinical Significance of ImmunoSequencing at 55th Annual Meeting of the American Society for Hematology

Adaptive Biotechnologies, the pioneer of Next Generation Sequencing (NGS) of the adaptive immune system, and its collaborators will present data...


25 Oct, 2013, 15:37 ET Adaptive Biotechnologies Publishes 'Gold Standard' Method for Sequencing Cells of the Adaptive Immune System

 Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, announced today the publication of a method...


17 Oct, 2013, 11:08 ET Adaptive Biotechnologies Receives Critical Intellectual Property for Next Generation Immunosequencing Field

Adaptive Biotechnologies Corporation, a pioneer in the field of genomic immune profiling, announced today that the Company has obtained a Notice of...


08 Oct, 2013, 11:08 ET Adaptive Biotechnologies Study Reveals Homogeneous Immune Repertoire in Solid Tumors

 Adaptive Biotechnologies Corporation, a leading provider of next-generation oncology diagnostics, today announced results from an ovarian...


13 Sep, 2013, 11:38 ET Adaptive Biotechnologies Receives $2.53 million Phase II SBIR to Develop Test to Identify Cancer Patients at Risk of Death by Infection after Cord Blood Transplants

Adaptive Biotechnologies announced today that it received a $2.53 million Phase II Small Business Innovation Research award from the National...


27 Jun, 2013, 11:08 ET Adaptive Biotechnologies and Biogen Idec Sign Immunological Services Agreement

Adaptive Biotechnologies announced today that it has signed an agreement with Biogen Idec for the study of the immune repertoire and the search...


09 May, 2013, 11:08 ET Adaptive Biotechnologies Signs Biomarker Discovery Collaboration Agreement with Bristol-Myers Squibb

 Adaptive Biotechnologies announced today that it has entered into a collaboration agreement with Bristol-Myers Squibb for the discovery of...


06 Dec, 2012, 14:07 ET Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.

Adaptive Biotechnologies, a leading provider of next-generation sequencing assays for the adaptive immune system, today introduced clonoSEQ, a...


16 May, 2012, 14:08 ET New Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More Sensitive than Traditional Method to Detect Minimal Residual Disease in Leukemia

 Adaptive Biotechnologies Corporation, a leading provider of next-generation sequencing assays for the adaptive immune system, announced today...


03 Jan, 2012, 11:08 ET Adaptive TCR Changes Name to Adaptive Biotechnologies

 Adaptive TCR Corporation, a leading provider of next generation sequencing assays for the adaptive immune system marketed under the...